Alzamend Neuro, Inc.

NasdaqCM:ALZN Stock Report

Market Cap: US$5.9m

Alzamend Neuro, Inc. Company Information

Alzamend Neuro, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Alzamend Neuro, Inc.
  • Ticker: ALZN
  • Exchange: NasdaqCM
  • Founded: 2016
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$5.863m
  • Shares Outstanding: 4.48m
  • Website: https://www.alzamend.com

Number of Employees

Location

  • Alzamend Neuro, Inc.
  • 3480 Peachtree Road NE
  • Second Floor, Suite 103
  • Atlanta
  • Georgia
  • 30326
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALZNNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJun 2021
9ZTDB (Deutsche Boerse AG)YesCommon StockDEEURJun 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 04:47
End of Day Share Price 2024/11/22 00:00
Earnings2024/07/31
Annual Earnings2024/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.